Список литературы

Поставить закладку

Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988, 124(6):869-871.
Leffell DJ, Carucci JA: Management of Skin Cancer. In: Cancer: Principles and Practice of Oncology 6th edition. edn. Edited by Devita VT, Hellman S, Rosenberg SA: Lippincott Williams & Wilkins.
Давыдов МИ, Аксель ЕМ: Статистика злокачественных новообразований в 2014 г. Данные по России. Евразийский онкологический журнал 2016, 4(4):824-861.
International Statistical Classification of Diseases and Related Health Problems 10th Revision [http://apps.who.int/classifications/icd10/browse/2016/en]
LeBoit PE, Burg G, Weedon D, Sarasin A (eds.): Pathology and Genetics of Skin Tumours. Lyon: IARCPress; 2006.
Sobin LH, Gospodarowicz MK, Wittekind C (eds.): The TNM classification of malignant tumours 8th edition, 8th edn: Wiley-Blackwell; 2009.
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S et al: Final version of 2009 AJCC melanoma staging and classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009, 27(36):6199-6206.
Bichakjian C, Olencki T, Aasi S, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Contreras CM, Daniels GA et al: NCCN Guidelines Version 1.2017 Squamous Cell Skin Cancer. In.: NCCN; 2017: 43.
Lotze TM, Dallal RM, Kirkwood JM, Flickinger JC: Cutaneous Melanoma. In: Cancer: Principles and Practice of Oncology 6th edition. edn. Edited by Devita VT, Hellman S, Rosenberg SA: Lippincott Williams & Wilkins.
Castro LG, Messina MC, Loureiro W, Macarenco RS, Duprat Neto JP, Di Giacomo TH, Bittencourt FV, Bakos RM, Serpa SS, Stolf HO et al: Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I. An Bras Dermatol 2015, 90(6):851-861.
Mun JH, Jwa SW, Song M, Ko HC, Kim BS, Kim MB, Kim HS: Pitfalls of using dermatoscopy in defining surgical margins of basal cell carcinoma. Dermatol Surg 2011, 37(11):1704-1705.
Bichakjian C, Olencki T, Aasi S, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Contreras CM, Daniels GA et al: NCCN Guidelines Version 1.2017. Basal Cell Skin Cancer. In.: NCCN; 2016.
Coit DG, Thompson JA, Albertini M, Algazi A, Andtbacka R, Bichakjian C, Carson WE, 3rd, Daniels GA, DiMaio D, Fields RC et al: NCCN Clinical Practice Guidelines in Oncology. Melanoma. Version 1.2017 In.: National Comprehensive Cancer Network, Inc; 2016: 161.
Bath-Hextall F, Bong J, Perkins W, Williams H: Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004, 329(7468):705.
Brodland DG, Zitelli JA: Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992, 27(2 Pt 1):241-248.
Bozan A, Gode S, Kaya I, Yaman B, Uslu M, Akyildiz S, Apaydin F, Ceylan C, Ozturk G: Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face. Dermatol Surg 2015, 41(7):761-767.
Wolf DJ, Zitelli JA: Surgical margins for basal cell carcinoma. Arch Dermatol 1987, 123(3):340-344.
Rowe DE, Carroll RJ, Day CL, Jr.: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26(6):976-990.
Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW: Surgical excision versus Mohs" micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years" follow-up. The Lancet Oncology 2008, 9(12):1149-1156.
ПУСТЫНСКИЙ ИН, КРОПОТОВ МА, ПАЧЕС АИ, ТКАЧЕВ СИ: РАК КОЖИ ГОЛОВЫ И ШЕИ. СОВРЕМЕННЫЕ ПОДХОДЫ К ВЫБОРУ МЕТОДА ЛЕЧЕНИЯ. СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ 2012(4):82-83.
Sandra A, Balachandran C, Shenoi SD, Sabitha L, Pai S, Ravikumar BC, Roy A: Cryotherapy in basal cell carcinoma. Indian J Dermatol Venereol Leprol 1999, 65(1):18-19.
McLean DI, Haynes HA, McCarthy PL, Baden HP: Cryotherapy of basal-cell carcinoma by a simple method of standardized freeze-thaw cycles. J Dermatol Surg Oncol 1978, 4(2):175-177.
Hibler BP, Sierra H, Cordova M, Phillips W, Rajadhyaksha M, Nehal KS, Rossi AM: Carbon dioxide laser ablation of basal cell carcinoma with visual guidance by reflectance confocal microscopy: a proof-of-principle pilot study. Br J Dermatol 2016, 174(6):1359- 1364.
Ortiz AE, Anderson RR, Avram MM: 1064 nm long-pulsed Nd:YAG laser treatment of basal cell carcinoma. Lasers Surg Med 2015, 47(2):106-110.
Roozeboom MH, Nelemans PJ, Mosterd K, Steijlen PM, Arits AH, Kelleners-Smeets NW: Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol 2015, 172(3):739-745.
Bu W, Zhang M, Zhang Q, Yuan C, Chen X, Fang F: Preliminary results of comparative study for subsequent photodynamic therapy versus secondary excision after primary excision for treating basal cell carcinoma. Photodiagnosis Photodyn Ther 2016.
Hambly R, Mansoor N, Quinlan C, Shah Z, Lenane P, Ralph N, Moloney FJ: Topical Photodynamic Therapy for Primary Bowen"s Disease and Basal Cell Carcinoma - Optimising Patient Selection. Br J Dermatol 2016.
Kessels JP, Dzino N, Nelemans PJ, Mosterd K, Kelleners-Smeets NW: Ambulatory Photodynamic Therapy for Superficial Basal Cell Carcinoma: An Effective Light Source? Acta Derm Venereol 2017.
Williams HC, Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, Surgery Versus Imiquimod for N, Superficial Basal Cell Carcinoma Study G: Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. The Journal of investigative dermatology 2016.
Singal A, Daulatabad D, Pandhi D, Arora VK: Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation. J Cutan Aesthet Surg 2016, 9(2):122-125.
Reymann F: Treatment of basal cell carcinoma with 5-fluorouracil (5-FU) ointment. Dermatologica 1970, 140:Suppl 1:34-41.
Naik MP, Mehta A, Abrol S, Kumar S, Gupta VS: Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach. Orbit 2016, 35(6):352-354.
Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA, Eastern Cooperative Oncology G: Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005, 23(34):8646-8654.
Dreno B, Basset-Seguin N, Caro I, Yue H, Schadendorf D: Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma. Oncologist 2014, 19(8):790-796.
Basset-Seguin N, Hauschild A, Grob JJ, Kunstfeld R, Dreno B, Mortier L, Ascierto PA, Licitra L, Dutriaux C, Thomas L et al: Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. The Lancet Oncology 2015, 16(6):729-736.
Chang AL, Solomon JA, Hainsworth JD, Goldberg L, McKenna E, Day BM, Chen DM, Weiss GJ: Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. J Am Acad Dermatol 2014, 70(1):60-69.
Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA, Eastern Cooperative Oncology G: Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005, 23(15):3562-3567.
Алгоритм осмотра кожи [http://melanoma-russia.ru/]
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6):649-655.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница